Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP384904.RATxLaU2Zpgki_z4LogxPj2_dz98LzSgLmRhFdZ39bH48130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP384904.RATxLaU2Zpgki_z4LogxPj2_dz98LzSgLmRhFdZ39bH48130_assertion type Assertion NP384904.RATxLaU2Zpgki_z4LogxPj2_dz98LzSgLmRhFdZ39bH48130_head.
- NP384904.RATxLaU2Zpgki_z4LogxPj2_dz98LzSgLmRhFdZ39bH48130_assertion description "[Blood samples were collected from 23 probands and 13 affected family members from 23 genetically unrelated Indian families (22 diagnosed as OCA and 1 diagnosed as OA) and analyzed by bidirectional DNA sequencing of the classic OCA genes--tyrosinase (TYR, or oculocutaneous albinism IA), pink eyed dilution (P; or oculocutaneous albinism II (OCA2]), tyrosinase-related protein 1 (TYRP1), solute carrier family 45, member 2 (SLC45A2; or membrane-associated transporter protein [MATP])--and the OA1 gene, G protein-coupled receptor 143 (GPR143).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP384904.RATxLaU2Zpgki_z4LogxPj2_dz98LzSgLmRhFdZ39bH48130_provenance.
- NP384904.RATxLaU2Zpgki_z4LogxPj2_dz98LzSgLmRhFdZ39bH48130_assertion evidence source_evidence_literature NP384904.RATxLaU2Zpgki_z4LogxPj2_dz98LzSgLmRhFdZ39bH48130_provenance.
- NP384904.RATxLaU2Zpgki_z4LogxPj2_dz98LzSgLmRhFdZ39bH48130_assertion SIO_000772 20806075 NP384904.RATxLaU2Zpgki_z4LogxPj2_dz98LzSgLmRhFdZ39bH48130_provenance.
- NP384904.RATxLaU2Zpgki_z4LogxPj2_dz98LzSgLmRhFdZ39bH48130_assertion wasDerivedFrom befree-20140225 NP384904.RATxLaU2Zpgki_z4LogxPj2_dz98LzSgLmRhFdZ39bH48130_provenance.
- NP384904.RATxLaU2Zpgki_z4LogxPj2_dz98LzSgLmRhFdZ39bH48130_assertion wasGeneratedBy ECO_0000203 NP384904.RATxLaU2Zpgki_z4LogxPj2_dz98LzSgLmRhFdZ39bH48130_provenance.